*New ATLL data presented in the first quarter; Company plans to request a meeting with the FDA on a regulatory pathway for cobomarsen in ATLL during Q2 2020
•Additional NIH grant funding released in support of MRG-229 for I...查看全文
WitnessBio2018-08-15 08:56
$Miragen Therapeutics, Inc.(MGEN)$ ATLL is driven by HTLV-1 infection. $MGEN reported that 2 patients treated w MRG-106, both w aggressive ATLL, had stable disease (tumor blood counts & lymphadenopathy) on cobomarsen for ≥6 mos. ATLL is poorly controlled w Zidovudine, IFN al...查看全文
WitnessBio2018-03-18 12:27
$Miragen Therapeutics, Inc.(MGEN)$ MGEN拥有可能是最好的MicroRNA平台。MicroRNA因为是non-coding,以前一直给制药业忽视,后来才发现它可以调控很多下游蛋白的表达。MGEN的在研药物现在为止没有像RGLS和MIRN两家一样出现grade 3以上的严重毒副作用。MRG-106刚刚出来的治疗mycosis fungoides(MF)...查看全文
淘沙见金2018-02-03 12:51
Moderna-biotech’s biggest unicorn is now worth $7.5 billion. 网页链接 How much would they worth if they IPO this year? Probably in $10-$15 billion range. Another mRNA company BioNTech raises $270M A round, put the...查看全文
$Miragen Therapeutics(MGEN)$ 8-K Current report, items 5.02, 5.03, 8.01, and 9.01 Accession Number: 0001590750-21-000013 Act: 34 Size: 564 KB 网页链接
$Miragen Therapeutics(MGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-002405 Size: 3 KB 网页链接
$Miragen Therapeutics(MGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-002402 Size: 6 KB 网页链接
$Miragen Therapeutics(MGEN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-21-000066 Act: 34 Size: 87 KB 网页链接
$Miragen Therapeutics(MGEN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-002233 Size: 3 KB 网页链接
$Miragen Therapeutics(MGEN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-21-002972 Act: 34 Size: 163 KB 网页链接
$Miragen Therapeutics(MGEN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001558370-21-000149 Act: 34 Size: 65 KB 网页链接
$Miragen Therapeutics(MGEN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-21-003722 Act: 34 Size: 132 KB 网页链接
$Miragen Therapeutics(MGEN)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-001414 Act: 34 Size: 100 KB 网页链接
$Miragen Therapeutics(MGEN)$ 8-K Current report, items 5.03, 5.07, 8.01, and 9.01 Accession Number: 0001590750-21-000003 Act: 34 Size: 230 KB 网页链接